IPQ Inside the global regulatory dialogue

FDASIA Heightens Focus on Proactive Communications with FDA; Timeliness, Accuracy and Transparency are Key, GMP Compliance Experts Advise

Jun 28th, 2014

Please Log in to print the full article

The provisions in the FDA Safety and Innovation Act (FDASIA) for communicating with FDA about manufacturing issues that could play out in drug shortages or facilitate regulatory surveillance are heightening industry’s focus on the agency’s...

You must be a paid subscriber to continue reading this article. If you are a paid subscriber, please Log in. If you are not a paid subscriber, please subscribe now.

©2021 IPQ Publications